Use of a Digital Modified Checklist for Autism in Toddlers – Revised with Follow-up to Improve Quality of Screening for Autism - 18/04/17
Abstract |
Objectives |
To assess changes in quality of care for children at risk for autism spectrum disorders (ASD) due to process improvement and implementation of a digital screening form.
Study design |
The process of screening for ASD was studied in an academic primary care pediatrics clinic before and after implementation of a digital version of the Modified Checklist for Autism in Toddlers – Revised with Follow-up with automated risk assessment. Quality metrics included accuracy of documentation of screening results and appropriate action for positive screens (secondary screening or referral). Participating physicians completed pre- and postintervention surveys to measure changes in attitudes toward feasibility and value of screening for ASD. Evidence of change was evaluated with statistical process control charts and χ2 tests.
Results |
Accurate documentation in the electronic health record of screening results increased from 54% to 92% (38% increase, 95% CI 14%-64%) and appropriate action for children screening positive increased from 25% to 85% (60% increase, 95% CI 35%-85%). A total of 90% of participating physicians agreed that the transition to a digital screening form improved their clinical assessment of autism risk.
Conclusions |
Implementation of a tablet-based digital version of the Modified Checklist for Autism in Toddlers – Revised with Follow-up led to improved quality of care for children at risk for ASD and increased acceptability of screening for ASD. Continued efforts towards improving the process of screening for ASD could facilitate rapid, early diagnosis of ASD and advance the accuracy of studies of the impact of screening.
Le texte complet de cet article est disponible en PDF.Keywords : M-CHAT, early detection
Abbreviations : ASD, EHR, M-CHAT, M-CHAT-R, M-CHAT-R/F, PDSA, WECO
Plan
Supported by the Duke Center for Autism and Brain Development; Duke Department of Psychiatry (PRIDe award); Duke Education and Human Development Initiative; Duke-Coulter Translational Partnership Grant Program; Information and Child Mental Health within the Information Initiative at Duke (iiD); and the National Center For Advancing Translational Sciences of the National Institutes of Health (TL1TR001116). Partial support also was received from the National Science Foundation and the Department of Defense. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the National Science Foundation, or the Department of Defense. The funding agencies did not impact the design, analysis, or writing of the manuscript. G.D. received authorship royalties from Guilford Publications and Oxford University Press and is on the scientific advisory boards of Janssen Research and Development, Roche Pharmaceuticals, Akili, Inc, and Progenity, Inc, for which she receives travel reimbursement and honoraria. K.L.H.C. serves as a paid consultant to the DC:0-3R Revision Task Force. The authors report the filing of a provisional patent that covers technology described in this manuscript. |
|
Portions of this study were presented as a poster during the Pediatric Academic Societies Meeting, Baltimore, MD, April 30, 2015. |
Vol 183
P. 133 - avril 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?